Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)

Yonsei University · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
canceregfrlung-cancernsclc
nsclc, cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873250
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.